NG
Goossens, Nicolas
Affiliation entities
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | 2024 | 59 | 20 | |||
Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | 2024 | 59 | 24 | |||
Élévation des tests hépatiques et maladies stéatosiques du foie : nouveautés 2024 | Revue médicale suisse | 2024 | 12 | 0 | |||
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | 2024 | 56 | 12 | |||
Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | 2024 | 48 | 13 | |||
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | 2024 | 38 | 11 | |||
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 60 | 11 | |||
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 17 | 16 | |||
Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | 2023 | 94 | 4 | |||
A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | 2023 | 54 | 27 | |||
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance | Scientific reports | 2023 | 117 | 25 | |||
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 26 | 18 | |||
Discontinuation of immunosuppression in patients with immune-mediated drug-induced liver injury or idiopathic autoimmune hepatitis: a case-control study | JGH open | 2023 | 51 | 42 | |||
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 59 | 16 | |||
A multi–society Delphi consensus statement on new fatty liver disease nomenclature | Journal of hepatology | 2023 | 71 | 16 | |||
Variable Intrafamilial Expression of ABCB4 Disease | ACG case reports journal | 2023 | 50 | 21 | |||
Abdominal pain patterns during COVID-19: an observational study | Scientific reports | 2022 | 199 | 49 | |||
Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model | Biomedicines | 2022 | 305 | 125 | |||
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 93 | 53 | |||
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 170 | 55 | |||
NAFLD and MAFLD as emerging causes of HCC: a populational study | JHEP Reports : Innovation in hepathology | 2021 | 233 | 115 | |||
Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing roux-en-y gastric bypass surgery: a propensity score-matched analysis | Obesity Surgery | 2021 | 181 | 73 | |||
Clinical presentation and gene expression of acute alcohol-induced microvesicular steatosis mimicking alcoholic hepatitis | Hepatology Communications | 2021 | 203 | 83 | |||
Management of acute Wilsonian hepatitis with severe hemolysis: a successful combination of chelation and MARS dialysis | Case Reports in Hepatology | 2021 | 187 | 101 | |||
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) | Journal of Hepatology | 2021 | 175 | 0 | |||
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies | Journal of Hepatology | 2020 | 261 | 1 | |||
Reply to: "Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma" | Journal of Hepatology | 2020 | 189 | 64 | |||
Management of hepatocellular carcinoma: SASL expert opinion statement | Swiss Medical Weekly | 2020 | 245 | 113 | |||
Disulfiram-induced acute liver injury | Case Reports in Dermatology Hepatology | 2020 | 297 | 97 | |||
Contribution of big data to biomarker and therapeutic discovery in liver disease | 2019 | 465 | 28 | ||||
RB519, RB520, RB521 and RB522 antibodies recognize the human ISOC1 protein by ELISA | Antibody Reports | 2019 | 334 | 85 | |||
Endovascular Treatment of Arterial Complications After Liver Transplantation: Long-Term Follow-Up Evaluated on Doppler Ultrasound and Magnetic Resonance Cholangiopancreatography | Cardiovascular and Interventional Radiology | 2019 | 272 | 350 | |||
Chirurgie abdominale chez les malades avec hypertension portale : implications et prise en charge | Revue médicale suisse | 2019 | 375 | 212 | |||
Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein | Liver International | 2019 | 401 | 228 | |||
Nonalcoholic fatty liver disease burden | Swiss Medical Weekly | 2019 | 262 | 121 | |||
Tolerogenic propreties of liver macrophages in non-alcoholic steatohepatitis | Liver International | 2019 | 394 | 398 | |||
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease | World Journal of Hepatology | 2018 | 405 | 274 | |||
A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis | European Journal of Gastroenterology and Hepatology | 2018 | 413 | 3 | |||
Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review | Journal of Viral Hepatitis | 2018 | 484 | 0 | |||
Cardiovascular Manifestations of Hepatitis C Virus | Clinics in Liver Disease | 2017 | 453 | 2 | |||
Hépatite B : nouvelles recommandations de prise en charge | Revue médicale suisse | 2017 | 504 | 2 | |||
Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review | Journal of Advanced Research | 2017 | 474 | 314 | |||
Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis | Gastroenterology | 2017 | 502 | 2 | |||
Liver volume is a prognostic indicator for clinical outcome of patients with alcoholic hepatitis | Abdominal radiology | 2017 | 575 | 82 | |||
Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance | Nature Communications | 2017 | 1,483 | 388 | |||
Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease | Nutrients | 2017 | 442 | 0 | |||
Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? | Stem cell research & therapy | 2017 | 504 | 186 | |||
Facteurs hépatiques pronostiques à long terme après chirurgie bariatrique | 2017 | 497 | 7 | ||||
Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers | Digestive diseases and sciences | 2017 | 546 | 1 | |||
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery | Clinical gastroenterology and hepatology | 2016 | 486 | 0 | |||
Drug Pricing Evolution in Hepatitis C | PloS one | 2016 | 1,312 | 582 | |||
Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis | Journal of hepatology | 2015 | 570 | 2 | |||
DOME/GALT type adenocarcimoma of the colon: a case report, literature review and a unified phenotypic categorization | Diagnostic pathology | 2015 | 532 | 191 | |||
Repenser la politique de remboursement des agents antiviraux directs contre l'hépatite C chronique | Revue médicale suisse | 2015 | 488 | 1 | |||
Extrahepatic manifestations of HCV | Minerva gastroenterologica e dietologica | 2015 | 504 | 0 | |||
Is genotype 3 of the hepatitis C virus the new villain ? | Hepatology | 2014 | 292 | 0 | |||
The impact of obesity and metabolic syndrome on chronic hepatitis C | Clinics in liver disease | 2014 | 512 | 0 | |||
Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection | Reviews on recent clinical trials | 2014 | 523 | 0 | |||
Morbidité et mortalité extrahépatiques associées à l'infection par le virus de l'hépatite C | Revue médicale suisse | 2014 | 519 | 1 | |||
Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report | Journal of Hepatology | 2013 | 548 | 0 | |||
Réactivation de l'hépatite B au cours de l'immunosuppression | Revue médicale suisse | 2013 | 553 | 0 | |||
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Hepatology | 2012 | 609 | 0 | |||
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis | BMC gastroenterology | 2011 | 670 | 290 | |||
Nouveaux traitements de l'hépatite C : quelles cibles, quel calendrier? | Revue médicale suisse | 2011 | 481 | 0 | |||
Role of nucleotides and phosphoinositides in the stability of electron and proton currents associated with the phagocytic NADPH oxidase | Biochemical journal | 2006 | 644 | 284 |